Targeting TCTP with Sertraline and Thioridazine in Cancer Treatment

Autor: Robert Amson, Judith E. Karp, Christian Auclair, Adam Telerman, Fabrice Andre
Přispěvatelé: Laboratoire de Biologie et de Pharmacologie Appliquée (LBPA), École normale supérieure - Cachan (ENS Cachan)-Centre National de la Recherche Scientifique (CNRS), Institut Gustave Roussy (IGR), Pathologie mammaire, Département de médecine oncologique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Biomarqueurs prédictifs et nouvelles stratégies moléculaires en thérapeutique anticancéreuse (U981), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Zdroj: TCTP/tpt1-Remodeling Signaling from Stem Cell to Disease
TCTP/tpt1-Remodeling Signaling from Stem Cell to Disease, 64, pp.283-290, 2017, ⟨10.1007/978-3-319-67591-6_15⟩
Results and Problems in Cell Differentiation ISBN: 9783319675909
Popis: International audience; We have initially demonstrated in knocking down experiments that decreasing TCTP in cancer cells leads in some tissues to cell death while in others to a complete reorganization of the tumor into architectural structures reminiscent of normal ones. Based on these experiments and a series of other findings confirming the key role of TCTP in cancer, it became important to find pharmacological compounds to inhibit its function, and this became for us a priority. In the present text, we explain in detail the experiments that were performed and the perspectives of sertraline in cancer treatment, as this became today a reality with a clinical study that started in collaboration with Columbia University and Johns Hopkins University.
Databáze: OpenAIRE